

Quark Pharmaceuticals is a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics. Among its major competitors, Quark Pharmaceuticals is ranked in 7th place for NPS while Allergan is 1st, and Adaptive Biotechnologies is 2nd.Their current valuation is $100.00M